Counterfeit drugs: Coming to a pharmacy near you

Journal of Pharmaceutical Finance, Economics and Policy

Volumn 16, Issue 3, 2008, Pages 3-42

  Yankus, Wyatt ^a  

^a American Council on Science and Health   (United States)

Author keywords

Counterfeiting; Misbranded medicines; Substandard drugs

Indexed keywords

ATORVASTATIN; CELECOXIB; HUMAN GROWTH HORMONE; ILLICIT DRUG; IMMUNOGLOBULIN; LAMIVUDINE PLUS ZIDOVUDINE; OLANZAPINE; OSELTAMIVIR; OXYCODONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SILDENAFIL; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTHRITIS; BIPOLAR DISORDER; DELUSION; DRUG COST; DRUG MARKETING; DRUG MONITORING; DRUG SAFETY; HALLUCINATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPOTENCE; INFORMATION SERVICE; INTERNET; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 67650568816     PISSN: 15385698     EISSN: 15385396     Source Type: Journal    
DOI: 10.1300/J371v16n03-02     Document Type: Review

References (80)

1. Adelman, Carol C., Jeremiah Norris and S. Jean Weicher. Access to Medicine: The Full Cost of HIV/AIDS Treatment, 2nd ed.. Hudson Institute, May 2005. http://spp.hudson.org/index.cfm?fuseaction = allFeatures.
2. Appleby, Julie. "U.S. Drug Supply a terrorism target?". USA Today, September 25, 2003. http://www.globaloptions.com/news-09-25-03.htm.
3. Ault, Alicia. "U.S. FDA calls for technological attack on drug counterfeiting." The Lancet, Vol. 363 (February 28, 2004): 714.
4. Beckett, Nick. "Technology, Media & Telecoms: A bitter pill." Legal Week, June 16, 2005.
5. Bernstein, Ilisa. "Pharmaceutical Product Integrity: Can the FDA Assure Quality?" in: "Reimportation of Pharmaceuticals" Supplement to Managed Care, Vol. 13, No. 3 (March 2004): 30-33.
6. Blum, Nancy. "Quality Control Approaches for Essential Medicines." In: Proceedings of World Bank Conference Good Intentions - Bad Drugs, March 10, 2005. http:// siteresources.worldbank.org/ INTAFRREGTOPHIVAIDS/Resources/gibd.htm.
7. Burnett, Francis. "Pharmaceutical Counterfeiting: A General Perspective." In: Pharmaceutical Counterfeiting Conference; April 26-27, 2004; Caribbean Industrial Research Institute, Trinidad and Tobago.
8. Catizone, Carmen. "Counterfeit Drugs and States' Efforts to Combat the Problem." Testimony before House Subcommittee on Criminal Justice, Drug Policy and Human Resources, July 11, 2006. http://reform.house.gov/CJDPHR/ Hearings/ EventSingle.aspx?EventID = 46631.
9. Cockburn, R., Newton, P., Agyarko, E.K., Akunyili, D., and White, N.. "The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers." PLoS Medicine, Vol. 2, Issue 4 e100 (April 2005): 302-308.
10. Cockburn, Robert. "Counterfeit drug racket." Science Show on ABC Radio National, February 4, 2006. http://abc.net.au/rn/ scienceshow/stories/2006/1559966.htm#.
11. Cockburn, Robert. "Death by Dilution." The American Prospect, December 20, 2005. http://www.prospect.org/web/page.ww?section= root&name=ViewPrint&articleId = 10650.
12. "Counterfeit Medicine-A Growing Health Threat." MedicalNewsToday.com. February 15, 2006. http://www.medicalnewstoday.com/ medicalnews.php?newsid=37819.
13. Couper, Mary R. Quality Problems With Antimalarials, World Health Organization Presentation. www.who.int/entity/hiv/-amds/ QualityAssuranceMalariaBKK.ppt.
14. Curley, Duncan and Lisa M. Ferri. United States: Trademark Rights vs. Gray Market Drug Imports. McDermott Will & Emory, May 30, 2006. http://www.mondaq.com/ i-article.asp-Q-articleid-E-40096.
15. deKieffer, Donald. "Counterfeit drugs in the supply chain." Pharmaceutical Business Strategies, September/October 2004.
16. deKieffer. Donald. "Continuing Concerns Over Imported Pharmaceuticals." Testimony before House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, June 7, 2001. http://energycommerce.house.gov/107/ hearings/06072001Hearing267/deKieffer407. htm.
17. deKieffer, Donald. "Trojan Drugs: Counterfeit and Mislabeled Pharmaceuticals in the Legitimate Market." American Journal of Law & Medicine, 32 (2006): 325-349.
18. Dondorp, A., Newton, P., Mayxay, M., Van Damme, W., Smithuis, F., Yeung, S., Petit, A., Lynam, A., Johnson, A., Hein, T., and others. "Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials." Tropical Medicine and International Health, Vol. 9 No. 12 (December 2004): 1241-1246.
19. Eban, Katherine. "Where Good and Bad Drugs Mix: Why drug importation poses real risks for American consumers." MedicalProgressToday.com, March 16, 2006. http://www.medicalprogresstoday.com/spotlight/spotlight- indarchive.php?id=1176.
20. Eban, Katherine. Dangerous Doses: How Counterfeiters Are Contaminating America's Drug Supply. New York: Harcourt, Inc., 2005.
21. FDA Press Release, "FDA Operation Reveals Many Drugs Promoted as 'Canadian' Products Really Originate From Other Countries," December 16, 2005, P05-102.
22. FDA Press Release, "FDA Test Results of Prescription Drugs from Bogus Canadian Website Show All Products Are Fake and Substandard," July, 13 2004. http:// www.fda.gov/bbs/topics/news/2004/NEW01087.html.
23. FDA Press Release: "FDA/U.S. customs import blitz exams reveal hundreds of potentially dangerous imported drug shipments," Sept. 29, 2003.
24. Flaherty, Mary Pat and Gilbert M. Gaul. "Canada is a Discount Pharmacy for Americans; FDA Doing Little to Stop Cross-Border Trade in Drugs." The Washington Post, October 23, 2003, A17.
25. Flaherty, Mary Pat and Gilbert M. Gaul. "Lax System Allows Criminals to Invade the Supply Chain." The Washington Post, October 22, 2003, A01.
26. Flaherty, Mary Pat and Gilbert M. Gaul. "Medicaid is Start of Drug Resale Trade." The Washington Post, October 22, 2003, A17.
27. Flaherty, Mary Pat and Gilbert M. Gaul. "Millions of Americans Look Outside U.S. for Drugs; Desire for Low Prices Often Outweighs Obeying Law." The Washington Post, October 23, 2003, A01.
28. Florida Supreme Court Case No. SC02-2645, "First Interim Report of the Seventeenth Statewide Grand Jury." (December 2003). http://www.myfloridalegal.com/ grandjury17.html.
29. Food and Drug Administration [FDA]. "Combating Counterfeit Drugs: A Report of the Food and Drug Administration." February 18, 2004. http://www.fda.gov/oc/initiatives/ counterfeit/report02-04.html.
30. Food and Drug Administration [FDA]. "Combating Counterfeit Drugs: A Report of the Food and Drug Administration Annual Update 2005." May 18, 2005. http://www. fda.gov/oc/initiatives/counterfeit/update2005.html
31. Food and Drug Administration [FDA]. "FDA Counterfeit Drug Task Force Report: 2006 Update." June 9. 2006. http://www.fda.gov/oc/initiatives/ counterfeit/report6-06. html.
32. Frenkiel, Olenka. "Bad Medicine." CBC News, Canadian Broadcasting Corporation, December 11, 2005. http://www.cbc.ca/correspondent/ feature-051211.html.
33. Gaul, Gilbert M. and Mary Pat Flaherty. "Doctors Medicate Strangers on Web; Some Physicians Face Own Troubles." The Washington Post, October 21, 2003, A01.
34. Gaul, Gilbert M. and Mary Pat Flaherty. "Internet Trafficking in Narcotics Has Surged." The Washington Post, October 20, 2003, A01.
35. Gaul, Gilbert M. and Mary Pat Flaherty. "U.S. Prescription Drug System Under Attack; Multibillion-Dollar Shadow Market is Growing Stronger." The Washington Post, October 19, 2003, A15.
36. Goldberg, Robert. "Drugs from Canada." The Washington Times, January 12, 2004. http://washingtontimes.com/op-ed/20040111-104452- 1984r.htm.
37. Goldberg, Robert. "Importing failure." The Washington Times, January 3, 2005. http:// www.washtimes.com/op-ed/20050102-090728- 8344r.htm.
38. Hansen, Chris. "Inside the world of counterfeit drugs." Dateline NBC, June 4, 2006. http://www.msnbc.msn.com/id/13137839/.
39. Hardie, Lawrence. "Counterfeit Drugs Are A Danger to Everyone." DrugNewswire, July 14, 2006. http://www.drugnewswire/3436.
40. Harper, Jonathan, Julian Morris, Graham Satchwell, Philip Stevens, David Taylor and Michael Tremblay. Coincidence or Crisis?: Prescription drug counterfeiting. London: The Stockholm Network, 2006.
41. Healthcare Distribution Management Association [HDMA]. "Recommended Guidelines for Pharmaceutical Distribution System Integrity." November 5, 2003. www.healthcaredistribution.org/gov-affairs/pdf-anti/Guidelines%20for%20Rx% 20Distribution%20System %20Integrity.pdf.
42. House Committee on Energy and Commerce Staff. "Memorandum: Imported Pharmaceutical Safety-Miami Internationnal Mail-Branch Facility Visit in March 2003." June 24, 2003. http://www.house.gov/commerce-democrats/press/ PDMAstaffreport. shtml.
43. International Council of Nurses [ICN]. Counterfeits kill: Nurses target counterfeit medicines. May 2005. http://www.icn.ch/indkit2005.pdf.
44. Kaufman, M, "FDA: Canadian drug position misinterpreted," The Washington Post, May, 26 2003: A11.
45. Kontnik, Lew. "Counterfeits: the cost of combat." Pharmaceutical Executive. November 1, 2003. http://www.pharmexec.com/ pharmexec/article/articleDetail.jsp?id = 75674
46. Kontnik, Lew. Pharmaceutical Counterfeiting: Preventing the Perfect Crime. Lew Kontnik Associates White Paper, (2004). www.fffenterprises.com/ web-files/fff-wht-ppr-111804.pdf.
47. Lutter, Randall W. Testimony before House Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 11, 2006. http://www.fda.gov/ola/2006/ counterfeit0711.html.
48. Mathews, Anna Wilde, and Heather Won Tesoriero. "FDA to Order Tracking of Medicines." Wall Street Journal, June 9, 2006, A2.
49. McKercher, Patrick L., ed. "Reimportation of Pharmaceuticals: Economic and Policy Implications," Supplement to Managed Care, Volume 13, No. 3 (March 2004). www.managedcaremag.com/supplements/0403-reimport/ MC-0403-reimport-suppl. pdf.
50. Meadows, Michelle. "Imported Drugs Raise Safety Concerns." FDA Consumer Magazine, September-October 2002. http://www.fda.gov/FDAC/ features/2002/502-import.html.
51. Morris, Julian, and Philip Stevens. Counterfeit medicines in less developed countries. London: International Policy Network, 2006. http://www.fightingdiseases.org/main/ index.php.
52. Newton, P., McGready, R., Fernandez, F., Green, M., Sunjio, M., Bruneton, C., Phanouvong, S., Millet, P., Whitty, C., Talisuna, A., and others. "Manslaughter by Fake Artensunate in Africa-Will Africa be Next?" PLoS Medicine, Volume 3, Issue 6, e197 (June 2006): 0001-0004.
53. Newton, Paul N., Nicholas J.White, JanA.Rozendaal, and Michael D.Green. "Murder by fake drugs: Time for international action." BMJ, Volume 324 (April 6, 2002): 800-801.
54. Olenka Frenkiel, "Bad Medicine" CBC News report, December 11, 2005.
55. Patton, Susannah. "Cracks in the Pharmaceutical Supply Chain." CIO Magazine, January 15, 2006. http://www.bio-itworld.com/newsitems/ 2006/january/11-18-06-news-supply-chain.
56. Pitts, Peter. "Counterfeit Drug Sales to Reach $75 Billion by 2010, Report Says." The Heartland Institute, November 1, 2005. http://www.heartland.org/Article.cfm? artId=17948.
57. Primo-Carpenter, Joyce. A Review of Drug Quality in Asia with Focus on AntiInfectives. United States Pharmacopeia Drug Quality and Information Program, February 2004. http://www.uspdqi.org/pubs/otherpubs.html.
58. Primo-Carpenter, Joyce. Matrix of Drug Quality Reports on USAID-assisted Countries. U.S. Pharmacopeia Drug Quality and Information Program, April 4, 2006. http://www.uspdqi.org/pubs/otherpubs.html.
59. Rudolf, Paul M. and Ilisa B.G. Bernstein. "Counterfeit drugs." New England Journal of Medicine, 350; 14 (April 1, 2004): 1384-1386.
60. Satchwell, Graham. Sick Business: Counterfeit medicines and organized crime. London: Stockholm Network, 2004.
61. Scheer, Adam. "Pharmaceutical Counterfeiting, Tampering and Diversion: The Threat to World Health and the Quest for Solutions." American Bank Note Holographics, Inc., December 2002. www.abnh.com/security/ Pharm-WhitePaper-WEBSITE.pdf.
62. Seyoum, Daniel, and Nancy Blum. Identification of Counterfeit and Sub-Standard Fixed-dose Combination Anti-Tuberculosis Drugs. U.S. Pharmacopeia, June 2003. http://www.uspdqi.org/pubs/otherpubs.html.
63. Shepherd, Marv. "Vulnerable Points in the U.S. Drug Distribution System." In "Reimportation of Pharmaceuticals" supplement to Managed Care, Vol. 13, No. 3 (March 2004): 25-29.
64. Siegel, Jeff. "Re-importation: The Issue That Will Not Die," Pharmaceutical Commerce, January 30, 2006. http://www. pharmaceuticalcommerce.com/frontEnd/main. php?idSeccion = 243.
65. Spies, Alan R., and Virgil Van Dusen. "Counterfeit Drugs: A Menace Keeps Growing." U.S. Pharmacist, Vol. No.: 28:01 (January 15, 2003). http://www. uspharmacist.com/index.asp?show = article&page = 8-1014.htm.
66. Stacy Lawrence, "FDA to Pharma: Where's the RFID?", eWeek, May 30, 2006. http:// www.eweek.com/article2/0,1895,1969912,00. asp.
67. Stearn, Douglas W. "Deterring the Importation of Counterfeit Pharmaceutical Products." Food and Drug Law Journal, vol. 59 (2004): 537-561.
68. Stevens, Philip. "Counterfeit Drugs: Getting to the root of the problem." MedicalProgressToday.com, March 24, 2006. http://www.medicalprogresstoday. com/spotlight/spotlight-indarchive.php?id = 1182.
69. Swickard, Joe. "Feds say smuggling ring helped fund Hezbollah." Detroit Free Press, March 29, 2006.
70. Taylor, John M. III, "Importation of Prescription Drugs." Testimony before Permanent Subcommittee on Investigations, Committee on Governmental Affairs, July 22, 2004.
71. USAID. (2004). Addressing Multidrug-Resistant Malaria in Asia. In Infectious Diseases. http://www.usaid.gov/our-work/global-health/id/malaria/ techareas/seasia-factsheet.html.
72. U.S. Immigration and Customs Enforcement. "ICE Efforts to Combat Counterfeit Pharmaceuticals," ICE Fact Sheet, July 11, 2006. http://www.ice.gov/pi/news/ factsheets/counterfeit-pharms.htm.
73. Vastag, Brian. "Alarm Sounded on Fake, Tainted Drugs: Some Wholesalers Are a Weak Link in a Dangerous Chain." JAMA, Vol. 290 No. 8 (August 27, 2003): 1015-1016.
74. World Health Organization. "General Information on counterfeit medicines." (2006). http://www.who.int/medicines/services/counterfeit/ overview/en/index.html.
75. World Heath Organization. "Counterfeit medicines," WHO Fact Sheet No. 275 (February 2006). http://www.who.int/mediacentre/factsheets/fs275/ en/.
76. Worley, Heidi. "Antimicrobial Resistance Jeopardizes Medical Advancement." PRB Online, February 2006. http://www.prb.org/ Template.cfm?Section=PRB&template=/ ContentManagement/ContentDisplay. cfm&ContentID=13548.
77. Yankus, Wyatt. "FDA Done Waiting for RFID." HealthFactsandFears.com, June 13, 2006. http://www.acsh.org/factsfears/ newsID.769/news-detail.asp.
78. Yankus, Wyatt. "Senate Importation Vote is Bad Medicine." HealthFactsandFears. com, July 11, 2006. http://www.acsh.org/factsfears/ newsID.797/news-detail.asp.
79. Young, Donna. "Secondary Wholesalers Oppose FDA Pedigree Regulation." ASHP News, American Society of Health-System Pharmacists, September 15, 2001. http:// www.ashp.org/news/ShowArticle.cfm?cfid= 66323&CFToken=97913798&id=2529.
80. Zucker, Howard. "Combating Counterfeit Drugs: Building Effective International Collaboration." In: Proceedings of WHO International Conference on Counterfeit Drugs; February 16-18 2006; Rome, Italy. http://mednet3.who.int/cft/